Tianyi Medical: Expected net loss of 11 million to 18 million yuan in 2025.

Tianyi Medical announced that it is expected to incur a net loss of 11 million to 18 million yuan in 2025. This year, the company's affiliated enterprises Ningbo Tianhuiyi Enterprise Management Co., Ltd. and its Singapore wholly-owned subsidiary TYHC International PTE. LTD have completed the delivery work of the CRRT business held by NKS. In 2025, the first year after the delivery, due to the combined impact of factors such as business, supply chain, personnel and organizational structure, and information system adjustments, its current operating performance is under pressure, leading to the recognition of investment losses by the company according to the equity method.